The Contribution of Multiplexing Single Cell RNA Sequencing in Acute Myeloid Leukemia

The Contribution of Multiplexing Single Cell RNA Sequencing in Acute Myeloid Leukemia

Decades ago, the treatment for acute myeloid leukemia relied on cytarabine and anthracycline. However, advancements in medical research have introduced targeted therapies, initially employing monoclonal antibodies such as ant-CD52 and anti-CD123, and subsequently utilizing specific inhibitors that t...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Lamia Madaci, Charlyne Gard, Sébastien Nin, Geoffroy Venton, Pascal Rihet, Denis Puthier, Béatrice Loriod, Régis Costello
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2023-07-01
Sarja:Diseases
Aiheet:
cell multiplexing
acute myeloid leukemia
single cell RNA sequencing
tumor heterogeneity
clonal evolution
targeted therapy
Linkit:https://www.mdpi.com/2079-9721/11/3/96

Internet

https://www.mdpi.com/2079-9721/11/3/96

Samankaltaisia teoksia